SEARCH RESULT

Total Matching Records found : 281

Can genes be patented?-Devangshu Datta

-The Business Standard Angelina Jolie has inadvertently highlighted a key question about patenting Angelina Jolies recent double mastectomy was obviously a very radical decision. It is unusual for a healthy person to opt for pre-emptive surgery to avert the probability, however high it may be, of getting cancer. The tests Jolie relied on are also at the heart of a legal battle, which could affect US biotech patenting norms. Since the US...

More »

Strong medicine for poor countries-Nayanima Basu

-The Business Standard The Novartis verdict by the Supreme Court emphasised the importance of flexibilities in drug patent laws, in contrast to Western countries which are seeking TRIPS-plus hardening through free-trade agreements As curtains on the six-year-long legal tussle with Swiss drug giant Novartis AG finally came down earlier this month, the Indian government did not waste a second in hailing the Indian patent law which it said was in "full...

More »

In the ‘pharmacy of the world’ -PT Jyothi Datta

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...

More »

The Larger Implications of the Novartis Glivec Judgment-Sudip Chaudhuri

-Economic and Political Weekly The Supreme Court judgment on the Novartis-Glivec case is remarkable because it has gone beyond the specific technical and legal issues surrounding patents and has put the matter in a much larger political and economic perspective. The deeper implication of the judgment is that it is not only justified to deny patents when incremental innovation is trivial as in the Glivec case. The judgment has linked the...

More »

Global scientists back 10-year moratorium on field trials of Bt food crops-Gargi Parsai

-The Hindu     They say Supreme Court-appointed panel's recommendations reasonable Even as the final report of the Supreme Court-appointed Technical Expert Committee (TEC) on open field trials of genetically modified crops is awaited, 51 independent international scientists with expertise in genetic engineering and biosafety protocols have approved the panel's Interim Report. The report has called for a 10-year moratorium on open field trials of Bt food crops until adequate regulatory mechanisms and safety...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close